Afficher la notice abrégée

Clinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99)

dc.rights.licenseopenen_US
hal.structure.identifierBoRdeaux Institute in onCology [Inserm U1312 - BRIC]
dc.contributor.authorMARGUE, Gaelle
hal.structure.identifierBoRdeaux Institute in onCology [Inserm U1312 - BRIC]
dc.contributor.authorBERNHARD, Jean-Christophe
dc.contributor.authorGIAI, Joris
dc.contributor.authorBOUZIT, Assilah
hal.structure.identifierBoRdeaux Institute in onCology [Inserm U1312 - BRIC]
dc.contributor.authorRICARD, Solene
hal.structure.identifierBoRdeaux Institute in onCology [Inserm U1312 - BRIC]
dc.contributor.authorJAFFREDO, Manon
dc.contributor.authorGUILLAUME, Benedicte
hal.structure.identifierBoRdeaux Institute in onCology [Inserm U1312 - BRIC]
dc.contributor.authorJAMBON, Eva
dc.contributor.authorFIARD, Gaelle
dc.contributor.authorBIGOT, Pierre
dc.contributor.authorWAECKEL, Thibaut
dc.contributor.authorSURLEMONT, Louis
dc.contributor.authorVERGIE, Stephane De
dc.contributor.authorBRANGER, Nicolas
dc.contributor.authorDOUMERC, Nicolas
dc.contributor.authorBOISSIER, Romain
dc.contributor.authorLANG, Herve
dc.contributor.authorAUDENET, Francois
dc.contributor.authorBEAUVAL, Jean-Baptiste
dc.contributor.authorBENSALAH, Karim
dc.contributor.authorDESCAZEAUD, Aurelien
dc.contributor.authorDAVID-TCHOUDA, Sandra
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRICHERT, Laura
dc.contributor.authorLONG, Jean-Alexandre
dc.contributor.authorDESCOTES, Jean-Lu
dc.date.accessioned2025-05-16T08:32:06Z
dc.date.available2025-05-16T08:32:06Z
dc.date.issued2025-04-07
dc.identifier.issn2588-9311en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206642
dc.description.abstractEnBACKGROUND AND OBJECTIVE: Renal cancer often requires nephron-sparing surgery for optimal patient outcomes. Despite advances in imaging and robot-assisted surgery, there is a need to enhance surgical precision and renal preservation. This trial evaluates the effectiveness of three-dimensional image-guided robot-assisted partial nephrectomy versus standard methods in improving surgical outcomes. CLINICAL TRIAL DESIGN AND TIMEFRAME: This trial is a prospective, 1:1 randomized, single-blind phase 3 superiority study conducted across 14 centers within the French Network for Research on Kidney Cancer, aiming to enroll 694 patients over 36 mo. ENDPOINTS: The primary endpoint is a composite trifecta score, including negative surgical margins, no complications, and renal function preservation (estimated glomerular filtration rate >90% at 1 mo). The secondary endpoints include oncological outcomes, conversion rates, perioperative parameters, and economic evaluation. DATA SOURCES AND STATISTICAL ANALYSIS PLAN: Data are collected via the UroCCR database. Logistic regression will analyze the primary endpoint, and various regression methods will address the secondary outcomes. Economic evaluations involve incremental cost-utility and cost-effectiveness ratios. STRENGTHS AND LIMITATIONS: Strengths include the multicenter design and robust randomization. Limitations involve variability in surgeons' experience with the new three-dimensional technology and logistical challenges in technology adoption. PATIENT SUMMARY: This clinical trial is designed to evaluate a new surgical technique for treating kidney tumors called three-dimensional (3D) image-guided robot-assisted partial nephrectomy. This study aims to determine whether this new method is more effective and safer than the current standard robot-assisted surgery by improving surgical precision and preserving kidney function. Kidney tumors require precise surgical removal to ensure the best outcomes for patients both during and after surgery. While robotic assistance has improved many surgeries, use of advanced 3D imaging during these procedures might enhance the surgeon's ability to operate with greater accuracy, potentially leading to better patient outcomes and fewer complications. Participants in the trial will undergo surgery using either the conventional robotic-assisted method or the new 3D image-guided technique. The method used for each participant will remain undisclosed to maintain the study's integrity. All participants will receive the highest standard of care, and their progress will be monitored closely throughout the trial. This study hopes to demonstrate that the 3D image-guided method can improve surgical precision and outcomes for patients undergoing kidney tumor removal. If successful, this technique could set a new standard for kidney surgery and improve the overall care patients receive in the future. The addition of 3D reconstruction to the surgery carries very little extra risk. If any technical issues occur, the surgeons can switch back to the regular method without affecting safety. The 3D technology we use, Synapse 3D, is approved and used in hospitals worldwide, ensuring that its safety is well proven by existing evidence.
dc.language.isoENen_US
dc.title.enClinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99)
dc.title.alternativeEur Urol Oncolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.euo.2025.03.012en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed40199643en_US
bordeaux.journalEuropean Urology Oncologyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionINRIAen_US
bordeaux.teamSISTM_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Urology%20Oncology&rft.date=2025-04-07&rft.eissn=2588-9311&rft.issn=2588-9311&rft.au=MARGUE,%20Gaelle&BERNHARD,%20Jean-Christophe&GIAI,%20Joris&BOUZIT,%20Assilah&RICARD,%20Solene&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_EUO_2025_Margue.pdf
Taille:
673.3Ko
Format:
PDF
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée